NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 156 filers reported holding NEOGENOMICS INC in Q2 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,821 | -26.0% | 148,032 | -3.2% | 0.00% | -33.3% |
| Q2 2023 | $2,460 | -11.3% | 152,948 | -4.0% | 0.01% | -14.3% |
| Q1 2023 | $2,772 | +82.5% | 159,253 | -3.1% | 0.01% | +75.0% |
| Q4 2022 | $1,519 | -99.9% | 164,420 | +2.6% | 0.00% | 0.0% |
| Q3 2022 | $1,378,000 | +37.4% | 160,177 | +30.2% | 0.00% | +33.3% |
| Q2 2022 | $1,003,000 | -24.5% | 122,996 | +15.4% | 0.00% | 0.0% |
| Q1 2022 | $1,329,000 | -63.2% | 106,621 | +0.8% | 0.00% | -57.1% |
| Q4 2021 | $3,610,000 | -28.9% | 105,792 | +1.3% | 0.01% | -41.7% |
| Q3 2021 | $5,074,000 | +11.8% | 104,404 | +3.9% | 0.01% | +20.0% |
| Q2 2021 | $4,539,000 | -6.0% | 100,504 | +0.3% | 0.01% | -16.7% |
| Q1 2021 | $4,829,000 | -16.9% | 100,167 | -7.2% | 0.01% | +9.1% |
| Q4 2020 | $5,811,000 | +28.7% | 107,942 | -11.8% | 0.01% | +10.0% |
| Q3 2020 | $4,515,000 | +9.5% | 122,397 | -8.1% | 0.01% | +11.1% |
| Q2 2020 | $4,123,000 | +9.2% | 133,150 | -2.6% | 0.01% | -10.0% |
| Q1 2020 | $3,775,000 | +0.8% | 136,767 | +5.9% | 0.01% | +25.0% |
| Q4 2019 | $3,745,000 | +27.1% | 129,135 | -3.9% | 0.01% | +14.3% |
| Q2 2019 | $2,947,000 | +12.4% | 134,353 | +4.7% | 0.01% | 0.0% |
| Q1 2019 | $2,622,000 | +2085.0% | 128,278 | +1202.2% | 0.01% | – |
| Q4 2018 | $120,000 | +22.4% | 9,851 | +53.9% | 0.00% | – |
| Q3 2018 | $98,000 | +16.7% | 6,400 | 0.0% | 0.00% | – |
| Q2 2018 | $84,000 | +61.5% | 6,400 | 0.0% | 0.00% | – |
| Q1 2018 | $52,000 | -8.8% | 6,400 | 0.0% | 0.00% | – |
| Q4 2017 | $57,000 | -19.7% | 6,400 | 0.0% | 0.00% | – |
| Q3 2017 | $71,000 | +24.6% | 6,400 | 0.0% | 0.00% | – |
| Q2 2017 | $57,000 | +14.0% | 6,400 | 0.0% | 0.00% | – |
| Q1 2017 | $50,000 | -9.1% | 6,400 | 0.0% | 0.00% | – |
| Q4 2016 | $55,000 | -47.1% | 6,400 | -50.0% | 0.00% | – |
| Q3 2016 | $104,000 | +103.9% | 12,800 | +100.0% | 0.00% | – |
| Q2 2016 | $51,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |